IWM
BBNX

Iams Wealth Management’s Beta Bionics BBNX Stock Holding History

Iams Wealth Management’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$157K Buy
+10,000
New +$119K 0.05% 189

Other funds holding BBNX

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
EF
Evanson Financial Mclean, Virginia $2.04B AUM
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
ATC
Adirondack Trust Company Saratoga Springs, New York $336M AUM 29.2% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
SIC
SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return

Iams Wealth Management's BBNX Position: Q2 2026 in Review

Iams Wealth Management opened a new position in Beta Bionics (BBNX) in Q2 2026: 10,000 shares worth $157K. The stake represents 0.05% of the portfolio and ranks #189 among its holdings.

15 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Iams Wealth Management held 10,000 shares of Beta Bionics worth $157K as of Q2 2026.
  • Beta Bionics was a new Iams Wealth Management position in Q2 2026.
  • Beta Bionics made up 0.05% of Iams Wealth Management's portfolio in Q2 2026, its #189 holding.
  • 15 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Iams Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.